$10.29
0.39% today
NYSE, Feb 05, 04:17 pm CET
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Evolent Health Inc Class A Stock price

$10.25
-1.75 14.58% 1M
-10.78 51.26% 6M
-1.00 8.89% YTD
-19.18 65.17% 1Y
-12.96 55.84% 3Y
+0.07 0.69% 5Y
-8.61 45.65% 10Y
NYSE, Closing price Tue, Feb 04 2025
+0.04 0.39%
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Key metrics

Market capitalization $1.19b
Enterprise Value $1.90b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 17.38
EV/Sales (TTM) EV/Sales 0.77
P/S ratio (TTM) P/S ratio 0.48
P/B ratio (TTM) P/B ratio 1.14
Revenue growth (TTM) Revenue growth 37.65%
Revenue (TTM) Revenue $2.46b
EBIT (operating result TTM) EBIT $10.86m
Free Cash Flow (TTM) Free Cash Flow $109.58m
Cash position $112.93m
EPS (TTM) EPS $-0.91
P/E forward negative
P/S forward 0.47
EV/Sales forward 0.74
Short interest 11.19%
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Evolent Health Inc Class A forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
93%
Hold
7%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,464 2,464
38% 38%
100%
- Direct Costs 2,190 2,190
50% 50%
89%
274 274
16% 16%
11%
- Selling and Administrative Expenses 144 144
19% 19%
6%
- Research and Development Expense - -
-
-
131 131
13% 13%
5%
- Depreciation and Amortization 120 120
8% 8%
5%
EBIT (Operating Income) EBIT 11 11
44% 44%
0%
Net Profit -72 -72
21% 21%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Neutral
PRNewsWire
one day ago
Richard " Rick "  Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb ' s Appointment as New Independent Director WASHINGTON , Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to...
Neutral
PRNewsWire
9 days ago
Company to Participate in Upcoming Conferences WASHINGTON , Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholde...
Neutral
PRNewsWire
about 2 months ago
Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025.
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,700
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today